antivirals

How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are
How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are
Fierce Pharma
China
COVID-19
branded pharma
generics
antivirals
Flag link:
How influenza discoveries could inspire a universal vaccine and new treatments
How influenza discoveries could inspire a universal vaccine and new treatments
Fierce Biotech
drug discovery
infuenza
antivirals
drug development
vaccines
Flag link:
Novartis licenses out early antiviral work to Gilead
Novartis licenses out early antiviral work to Gilead
Fierce Biotech
Gilead Sciences
Novartis
antivirals
Flag link:
J&J stalls development of antiviral from Alios deal
J&J stalls development of antiviral from Alios deal
BioCentury
JNJ
antivirals
Alios BioPharma
AL-8176
lumicitabine
Flag link:
Roche’s antiviral hits flu targets in PhIII trial
Roche’s antiviral hits flu targets in PhIII trial
Pharma Times
Roche
baloxavir marboxil
antivirals
Flu
Shionogi
Flag link:
Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs
Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs
Endpoints
Novartis
R&D
antibiotics
antivirals
layoffs
Flag link:
Teva rolls out exclusive generic of Gilead's Viread at the end of an awful week
Teva rolls out exclusive generic of Gilead's Viread at the end of an awful week
Fierce Pharma
Teva Pharmaceutical
Gilead Sciences
Viread
hepatitis B
HIV
antivirals
Flag link:
Merck says its antiviral medicine met late-stage primary endpoint
Merck says its antiviral medicine met late-stage primary endpoint
Marketwatch
Merck
antivirals
clinical trials
letermovir
stem cell transplant
Flag link:
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Fierce Biotech
Chimerix
clinical trials
Brincidofovir
CMV
antivirals
Flag link:
The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral
The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral
Seeking Alpha
FDA
Rapivab
Biocryst
Flu
antivirals
Flag link:
Biota Pharma's Game-Changer, Laninamivir: Are You Ready For The Next Pandemic Flu?
Biota Pharma's Game-Changer, Laninamivir: Are You Ready For The Next Pandemic Flu?
Seeking Alpha
Biota
Laninamivir
Flu
antivirals
Flag link:
Teva Pharma to buy $7.5 million stake in Cocrystal Discovery, which studies antiviral drugs
Teva Pharma to buy $7.5 million stake in Cocrystal Discovery, which studies antiviral drugs
Yahoo/AP
Teva Pharmaceuticals
Cocrystal Discovery
antivirals
Flag link:
FDA OKs generic Valtrex from Teva
FDA OKs generic Valtrex from Teva
Bizjournals.com
FDA
generics
Teva Pharmaceuticals
Valtrex
antivirals
GSK
Flag link:
Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug
Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug
Bloomberg
Daiichi Sankyo
Japan
Flu
antivirals
Laninamivir
Flag link:
FDA Approves Use of Experimental Antiviral For H1N1 Flu
FDA Approves Use of Experimental Antiviral For H1N1 Flu
WSJ Online
antivirals
Biocryst
swine flu
H1N1
FDA
Flag link:
Gilead Sciences: Expect Share Price to Move Up
Gilead Sciences: Expect Share Price to Move Up
Seeking Alpha
Gilead Sciences
antivirals
Flag link:

Pages